Kingworld Medicines Group Ltd 2024 SR
The report highlights Kingworld Medicines Group's commitment to the pharmaceutical and healthcare industry, focusing on supply chain management and sustainable development. In 2024, the company achieved a 3% reduction in non-hazardous solid waste and a 2.9% reduction in hazardous waste at its Dong Di Xin subsidiary. The Group actively managed climate risks through emergency plans for typhoons and floods. Socially, the company maintained a workforce of 972 employees with a 51.9% female ratio and invested approximately RMB 8.44 million in charitable donations, including disaster relief and educational support.
Company: Kingworld Medicines Group Ltd
Sector: Health Care
Country: China
Year: 2024
Type: SR
Pages: 44
Kingworld Medicines Group Ltd
ESG Report
The report highlights Kingworld Medicines Group's commitment to the pharmaceutical and healthcare industry, focusing on supply chain management and sustainable development. In 2024, the company achieved a 3% reduction in non-hazardous solid waste and a 2.9% reduction in hazardous waste at its Dong Di Xin subsidiary. The Group actively managed climate risks through emergency plans for typhoons and floods. Socially, the company maintained a workforce of 972 employees with a 51.9% female ratio and invested approximately RMB 8.44 million in charitable donations, including disaster relief and educational support.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Workplace Fatalities
Employees